Login / Signup

Do Clinicians Have a Duty to Participate in Pragmatic Clinical Trials?

Andrew GarlandStephanie R MorainJeremy Sugarman
Published in: The American journal of bioethics : AJOB (2022)
Clinicians have good moral and professional reasons to contribute to pragmatic clinical trials (PCTs). We argue that clinicians have a defeasible duty to participate in this research that takes place in usual care settings and does not involve substantive deviation from their ordinary care practices. However, a variety of countervailing reasons may excuse clinicians from this duty in particular cases. Yet because there is a moral default in favor of participating, clinicians who wish to opt out of this research must justify their refusal. Reasons to refuse include that the trial is badly designed in some way, that the trial activities will violate the clinician's conscience, or that the trial will impose excessive burdens on the clinician.
Keyphrases
  • palliative care
  • clinical trial
  • study protocol
  • phase ii
  • phase iii
  • healthcare
  • open label
  • randomized controlled trial
  • primary care
  • double blind
  • decision making
  • body mass index
  • resting state